-
Product Insights
NewReproductive Health Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Reproductive Health Devices Pipeline Market Report Overview Endometrial ablation devices, female sterilization devices, reversible contraceptive devices, and assisted reproductive technology devices are the main categories of reproductive health devices. The reproductive health devices pipeline report provides comprehensive information about the main products with their comparative segment-wise analysis at various stages of development. The report also covers the regional and country-wise reproductive health devices clinical trials outlook. The regulatory paths followed for conducting the reproductive health devices pipeline research are also...
-
Company Profile
Biocept Inc – Company Profile
Biocept Inc (Biocept) is a molecular diagnostics company. It develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. The company offers assays for solid tumor indications, including breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE, Target Selector,...
Add to Basket -
Product Insights
Non-Invasive Prenatal Testing (NIPT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Non-invasive prenatal screening is a method that determines the risk of genetic abnormalities in the fetus. The Non-invasive prenatal testing (NIPT) pipeline market research report provides comprehensive information about the Non-invasive prenatal testing (NIPT) pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Prenatal Screening Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Prenatal Screening Tests includes the sub-segments Free Beta Human Chorionic Gonadotropin (hCG) Tests, Pregnancy Associated Plasma Protein A (PAPP-A) Tests, Total Human Chorionic Gonadotropin (hCG) Tests, Unconjugated Estriol (uE3) Tests, Alpha-Fetoprotein (AFP) Tests and Inhibin A Tests. GlobalData's Medical Devices sector report, “Prenatal Screening Tests - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Prenatal Screening Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which...
-
Product Insights
COVID 19 Nucleic Acid Amplification Tests (NAATs) – Medical Devices Pipeline Assessment, 2020
COVID 19 NAAT tests are highly sensitive tests and can easily detect the low density infections. The types of NAAT tests are Polymerase chain reaction (PCR) – including nested (n), quantitative (q) or real-time reverse transcription (RT) PCR), quantitative nucleic acid sequence-based amplification (QT-NASBA) and loop mediated isothermal amplification (LAMP). GlobalData's Medical Devices sector report, “COVID 19 Nucleic Acid Amplification Tests (NAATs) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the COVID 19 Nucleic Acid Amplification Tests (NAATs)...
-
Product Insights
Lung Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Lung Cancer Diagnostic Tests include assays of mostly antibodies released in response to a lung cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Lung Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Lung Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...